Skip to content

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy- a Prospective Randomized Controlled Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04675840
Enrollment
100
Registered
2020-12-19
Start date
2020-11-01
Completion date
2022-06-30
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Brief summary

Is there any difference in the intensity of postoperative pain, nausea, urinary retention and legth of hospital stay in patients undergoing robotic assisted laparoscopic surgery if they receive intrathecal morphine or peroral and intravenous opiates during the surgery and is there a significant difference in the need of opiates after the surgery.

Interventions

Robotic-assisted surgery

Sponsors

Karlstad Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\* Patients accepted for robotic-assisted laparoscopic surgery

Exclusion criteria

* Coagulopathy, * Prior spine surgery, * Chronic pain problems, * Drug abuse, * Pregnancy * \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
Postop morphine consumptionFirst 48 hours after surgeryAmount of opiates given postop
Postop grade of nausea & vomitingFirst 24 hours after surgeryAmount of antemetics given

Secondary

MeasureTime frameDescription
Hospital length of stay.Up to 7 daysTime from surgery (day 0) until Fit For Discharge FFD, defined as: 1) is taking oral pain medication only; 2) is able to walk around independently; 3) is tolerating full oral diet and have bowel movements; 4) is hemodynamically an respiratory stable; 5) has no drains or urinary catheter.
Patient overall satisfaction score.Up to 7 days.1-10, where 1 is unsatisfied and 10 is very satisfied.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026